UnitedHealth Group (NYSE:UNH) Downgraded to Outperform at Raymond James

UnitedHealth Group (NYSE:UNHGet Rating) was downgraded by analysts at Raymond James from a “strong-buy” rating to an “outperform” rating in a research report issued on Monday, The Fly reports.

A number of other analysts have also recently issued reports on UNH. Credit Suisse Group lifted their price objective on UnitedHealth Group from $579.00 to $590.00 and gave the company an “outperform” rating in a research report on Monday, October 17th. Mizuho lifted their price objective on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Argus boosted their price target on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. Royal Bank of Canada boosted their price target on UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a research report on Monday, October 17th. Finally, SVB Leerink reduced their price target on UnitedHealth Group from $625.00 to $618.00 and set an “outperform” rating for the company in a research report on Monday, October 17th. Three analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $595.11.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $530.00 on Monday. UnitedHealth Group has a 1-year low of $436.00 and a 1-year high of $558.10. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $495.20 billion, a price-to-earnings ratio of 25.95, a P/E/G ratio of 1.65 and a beta of 0.75. The stock’s fifty day simple moving average is $523.75 and its 200-day simple moving average is $515.28.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, October 14th. The healthcare conglomerate reported $5.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.45 by $0.34. The firm had revenue of $80.89 billion during the quarter, compared to analysts’ expectations of $80.54 billion. UnitedHealth Group had a return on equity of 26.59% and a net margin of 6.17%. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the firm earned $4.52 earnings per share. On average, sell-side analysts predict that UnitedHealth Group will post 22.01 earnings per share for the current fiscal year.

Insider Activity

In other news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.40% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Several large investors have recently modified their holdings of UNH. TimeScale Financial Inc. grew its position in UnitedHealth Group by 276.9% during the 3rd quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate’s stock worth $25,000 after acquiring an additional 36 shares during the last quarter. Pflug Koory LLC lifted its holdings in UnitedHealth Group by 160.0% during the 3rd quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 32 shares in the last quarter. Urban Wealth Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth $29,000. Knott David M Jr acquired a new position in UnitedHealth Group during the 2nd quarter worth $29,000. Finally, Rothschild & Co Wealth Management UK Ltd acquired a new position in UnitedHealth Group during the 2nd quarter worth $31,000. 87.25% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.